
We are excited to announce the semi-finalists for the Disability:IN 2023 Pitch Perfect Challenge!
During the semi-finals, DOBEs will give their virtual pitches live to corporate decision-makers and fellow entrepreneurs. Three DOBEs, including one “People’s Choice” to be selected via social voting, will advance to the Final Round at the Disability:IN Global Conference in July.

Ashley T. Brundage, President
Empowering Differences
Empowering Differences is an organization founded on the 10 Empowering Actions used by founder Ashley T Brundage to advance her career in less than five years from a homeless part-time bank teller to the National Vice President of Diversity & Inclusion while working at PNC Bank in the United States of America.

Fiona Dawson, Director

Timothy Cornelius, Founder & CEO
P3 Technology, LLC
P3 Technology is more than just a disability-owned and operated company – they’re a catalyst for change. Their team provides the invaluable insights companies need to truly understand and serve their disabled customers. They guide businesses in breaking down accessibility barriers, instilling inclusivity in their market research, product development, and services. More than reshaping products and services, they’re transforming the world into one where disability is a celebrated part of our society.

John Reid, President
Sky Inc.
SKY is a Los Angeles-based psychological brand design studio that helps companies to combine positive purpose with the power of leading-edge brand development. Their focuses are elevated brand strategy, film and video, marketing, creative services, and consulting. Together, these offerings provide SKY’s clients with a comprehensive “brand platform.” The results are brands that outperform their competition and inspire their audiences.

Jeanette Towles, President
Synterex, Inc.
Synterex is a WBENC-Certified Women’s Business Enterprise and disability-owned global clinical and regulatory consulting firm that provides clinical writing and development solutions. They are committed to applying years of experience, current subject matter expertise, and technical knowledge to help clients deliver important new therapies to patients in an expedient manner.